Literature DB >> 32940406

Autism spectrum conditions in hikikomori: A pilot case-control study.

Ryoko Katsuki1, Masaru Tateno2,3, Hiroaki Kubo1, Keita Kurahara1, Kohei Hayakawa1, Nobuki Kuwano1, Shigenobu Kanba1, Takahiro A Kato1.   

Abstract

AIM: Hikikomori, a form of pathological social withdrawal, has been suggested to have comorbidity with autism spectrum disorder (ASD). This study aimed to clarify how characteristics of hikikomori are associated with ASD, including undiagnosed autism spectrum conditions (ASC), in clinical settings.
METHODS: A total of 416 clinical patients were recruited through the Mood Disorder/Hikikomori Clinic at Kyushu University Hospital. A total of 103 hikikomori cases and 221 clinical controls without hikikomori conditions were extracted using a semi-structured interview, and completed a series of self-rated scales, including the Japanese version of the Autism-Spectrum Quotient (AQ-J).
RESULTS: Compared to non-hikikomori controls, hikikomori cases were more likely to have higher autistic tendency based on the AQ-J. The cases showed more severe subjective depressive symptoms based on the self-rated Beck Depression Inventory II, whereas no significant difference was found on interview-based severity evaluation using the Hamilton Depression Rating Scale. Comparison within hikikomori cases based on the AQ-J cut-off score revealed that hikikomori cases with high ASC were significantly more likely to have higher traits of modern-type depression, smaller social networks, and less social support.
CONCLUSION: The present data suggest that hikikomori sufferers are more likely to have autistic tendency, and that hikikomori sufferers with high ASC may have much more difficulty in social communication and social interaction. In addition, those with high ASC may also have lower self-esteem and higher complaint tendencies as aspects of modern-type depression traits, which may relate to the occurrence of hikikomori. Thus, evaluating autistic tendencies is important for appropriate interventions in hikikomori. Further investigations should be conducted to validate our pilot findings using structured diagnostic systems of ASD.
© 2020 The Authors Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  autism spectrum conditions; hikikomori; modern-type depression; narcissism; social withdrawal

Year:  2020        PMID: 32940406     DOI: 10.1111/pcn.13154

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  4 in total

1.  Blood metabolic signatures of hikikomori, pathological social withdrawal.

Authors:  Daiki Setoyama; Toshio Matsushima; Kohei Hayakawa; Tomohiro Nakao; Shigenobu Kanba; Dongchon Kang; Takahiro A Kato
Journal:  Dialogues Clin Neurosci       Date:  2022-06-01

2.  Relationship between autistic traits and social functioning in healthy individuals.

Authors:  Yuria Demizu; Junya Matsumoto; Yuka Yasuda; Satsuki Ito; Kenichiro Miura; Hidenaga Yamamori; Michiko Fujimoto; Naomi Hasegawa; Keiichiro Ishimaru; Ryota Hashimoto
Journal:  Neuropsychopharmacol Rep       Date:  2022-04-01

3.  Autistic children and adolescents with frequent restricted interest and repetitive behavior showed more difficulty in social cognition during mask-wearing during the COVID-19 pandemic: a multisite survey.

Authors:  Hiroki Tamon; Takashi Itahashi; Sosei Yamaguchi; Yoshiyuki Tachibana; Junya Fujino; Miki Igarashi; Makiko Kawashima; Riina Takahashi; Nozomi A Shinohara; Yoshihiro Noda; Shinichiro Nakajima; Tomoya Hirota; Yuta Y Aoki
Journal:  BMC Psychiatry       Date:  2022-09-14       Impact factor: 4.144

4.  Prevalence and Characteristics of Social Withdrawal Tendency Among 3-24 Months in China: A Pilot Study.

Authors:  Fengjuan Zhou; Peiyuan Huang; Xueling Wei; Yixin Guo; Jinhua Lu; Lanlan Feng; Minshan Lu; Xian Liu; Si Tu; Alexandra Deprez; Antoine Guedeney; Songying Shen; Xiu Qiu
Journal:  Front Psychiatry       Date:  2021-06-16       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.